At‑home lab consolidation
- Function Health acquired Getlabs to expand its at-home lab testing and mobile phlebotomy capabilities. - The acquisition brings Getlabs' consumer-facing at-home blood draw services into Function Health's offering. - The deal reflects growing experimentation with bundling diagnostics access into broader consumer engagement channels. (x.com)
Function Health said on April 8 that it acquired Getlabs, adding at-home blood draws to its consumer lab-testing business. (prnewswire.com) Function sells a $365-a-year membership that includes 160-plus lab tests and access to more than 2,000 Quest Diagnostics locations nationwide. Getlabs sends mobile phlebotomists to homes and offices and delivers samples to Quest and Labcorp for testing. (functionhealth.com) (getlabs.com) Function said the deal will let members choose between going to a lab site or booking a blood draw at home or at work. Fierce Healthcare reported the companies did not disclose financial terms. (prnewswire.com) (fiercehealthcare.com) A blood test still has to be collected somewhere, and that last step has been one of the main frictions in direct-to-consumer diagnostics. Getlabs built its business around that step, offering same-day, nationwide mobile visits for labs, vitals, and other diagnostics. (getlabs.com) Function has been expanding beyond a single annual lab panel into a broader health-membership product. Its site now markets lab testing, add-on scans, and at-home kit options under one subscription. (functionhealth.com 1) (functionhealth.com 2) The acquisition also lands as Function scales quickly. In November 2025, the company said it had raised a $298 million Series B at a $2.5 billion valuation and had hundreds of thousands of members. (functionhealth.com) Getlabs, founded in 2018, had already been selling home diagnostics logistics to healthcare organizations before this deal. Its pitch to partners was simple: send a licensed specialist to the patient instead of asking the patient to travel to a lab. (getlabs.com) Modern Healthcare described the acquisition as an expansion of Function’s user-facing lab services, a sign that consumer health companies are trying to own both the test order and the collection experience. (modernhealthcare.com) The immediate change for customers is straightforward: Function is no longer just selling access to lab results and explanations. It is moving to control the house call that gets the blood drawn in the first place. (prnewswire.com)
